Genome Institute of Singapore (GIS)
Vanda (Papilionanthe) Miss Joaquim’s genome in full bloom18 May 2023
Scientists discover genes encoding colours, scents and bioactive compounds in the genome of Papilionanthe Miss Joaquim, Singapore’s National Flower.
How cancer seizes the immortality gene21 Apr 2023
Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.
Genetic tool unveils TB bacteria’s ‘malware’8 Feb 2023
Using a new genome analysis technology, A*STAR scientists discover never-before-seen immune responses in tuberculosis infections.
On target for the precision health era30 Dec 2022
Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.
The mind cartographer22 Dec 2022
Through innovative molecular technologies, Jinyue Liu is building maps of the brain’s circuitry to better understand how these connections go awry in disease.
Remedy for a fragile heart27 Sep 2022
Experimental gene therapy promises a new lease of life for patients with genetic heart disease.
Expanding the tumour cell catalogue16 Sep 2022
New gastric cancer insights come to light with the help of powerful single-cell technologies.
A wide-angle view of cancer evolution29 Jul 2022
Cancer genetics experts say new technologies and more comprehensive data collection are required to deepen our understanding of tumour lifecycles.
Unravelling the ancestry of a unique community13 Jul 2022
By looking at Peranakan Chinese genomes, researchers confirm the community arose from genetic mixing between local Malay women and foreign Chinese traders in the past.
Bringing a major culprit in advanced gastric cancer to light5 Jul 2022
Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.
Speaking the same immune language12 May 2022
The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.
Delivering therapies to the heart’s core7 Apr 2022
Nuevocor, an A*STAR spin-off company, is designing novel therapies to target the genetic causes of heart diseases, bringing basic research to clinical impact.